» Articles » PMID: 18511049

A Randomized, Controlled, Double-blind Trial of the Adjunct Use of Tegaserod in Whole-dose or Split-dose Polyethylene Glycol Electrolyte Solution for Colonoscopy Preparation

Overview
Date 2008 May 31
PMID 18511049
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Problems of compliance, quality, and safety of colon preparation regimens have prompted continued investigation with alternative forms of cleansing.

Objective: To evaluate the efficacy of tegaserod as an adjunct to a polyethylene glycol electrolyte solution (PEG-E), given as a whole dose or split dose, in colonoscopy preparation.

Design: Randomized, placebo-controlled, double-blind trial.

Setting: A single university-based hospital.

Patients: Patients who were undergoing elective colonoscopy.

Interventions: A 4-arm randomization scheme that compared tegaserod with a placebo, each with whole-dose or split-dose PEG-E preparation.

Main Outcome Measurements: Efficacy of colon cleansing was the primary outcome. Secondary outcomes included adherence, tolerability, adverse effects, and patient perceptions of their preparation quality.

Results: A total of 382 patients completed the trial. Patients who received the split-dose preparation had significantly better colon cleansing than those who received the whole-dose preparation (88.9% vs 42.6%, P < .001). The addition of tegaserod did not significantly improve the overall colonoscopy preparation quality compared with a placebo. However, there were fewer poor preparations in the whole-dose PEG-E group (12.4% vs 1.1%, P = .002, Bonferroni correction removes significance) and more excellent preparations in the split-dose group (53.3% vs 38.3%, P = .035, Bonferroni correction removes significance) in favor of tegaserod. Interobserver and intraobserver variability analysis showed substantial agreement among endoscopists. Adherence was significantly lower in the whole-dose group versus the split-dose PEG-E group (68.8% vs 91%, P < .001), independent of the use of tegaserod. Adverse effects were not different between study groups.

Limitations: A 4-arm randomization and the single-center nature of the study.

Conclusions: Tegaserod has a marginal effect on the quality of colonoscopy preparation when used as an adjuvant to PEG-E. The split-dose PEG-E was superior to the whole-dose PEG-E and resulted in better colon cleansing, adherence, and tolerance.

Citing Articles

Day before late regimen vs standard split dose of low-volume PEG-CS for early morning colonoscopy: Multicenter randomized controlled trial.

Pasquale L, Grande G, Zagari R, Biancheri P, Pisani A, Da Massa Carrara P Endosc Int Open. 2025; 13:a25158539.

PMID: 40007647 PMC: 11855237. DOI: 10.1055/a-2515-8539.


Split doses versus whole dose bowel preparation using polyethylene glycol for colonoscopy: A multicentric prospective Lebanese randomized trial between 2021 and 2023.

Sara B, Ghinwa H, Layla M, Mahmoud H, Ali K, Remy M Health Sci Rep. 2024; 7(4):e2047.

PMID: 38655418 PMC: 11035750. DOI: 10.1002/hsr2.2047.


Prospective, randomized study comparing two different regimens of split-dose polyethylene glycol and their effect on endoscopic outcomes.

Abou Zeid J, Hallit S, Akiki B, Abou Zeid Z, Yazbeck C BMC Gastroenterol. 2024; 24(1):132.

PMID: 38609900 PMC: 11010337. DOI: 10.1186/s12876-024-03212-z.


Colonoscopy: Preparation and Potential Complications.

Latos W, Aebisher D, Latos M, Krupka-Olek M, Dynarowicz K, Chodurek E Diagnostics (Basel). 2022; 12(3).

PMID: 35328300 PMC: 8947288. DOI: 10.3390/diagnostics12030747.


Polyethylene glycol plus bisacodyl: A safe, cheap, and effective regimen for colonoscopy in the South Asian patients.

Jha A, Chaudhary M, Jha P, Kumar U, Dayal V, Jha S JGH Open. 2019; 2(6):249-254.

PMID: 30619933 PMC: 6308092. DOI: 10.1002/jgh3.12077.